Zoledronic acid Recruiting Phase 4 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02286830Prolonged Protection From Bone Disease in Multiple Myeloma